La catena delle opzioni mostra i dati chiave delle opzioni azionarie di 8x8 a vari prezzi di esercizio e date di scadenza. I trader utilizzano queste informazioni per analizzare potenziali operazioni e valutare il sentiment del mercato per 8x8..

8x8 (NASDAQ:EGHT) Azioni, Catena delle Opzioni

8x8 Inc provides contact-center-as-a-service and unified-communications-as-a-service software applications to approximately 2.5 million users. The company's unified platform enables omnichannel communication to assist employees in communicating across voice, video, text, chat, and contact centers. The Company also generates revenue from sales of hardware and professional services, which are complementary to the delivery of its integrated technology platform.. Geographically, it derives a majority of revenue from the United States.

8x8 Inc

Morgan Stanley analyst Meta Marshall maintains 8x8 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EGHT#NASDAQ">EGHT</a>) with a Underweight and lowers the price target from $2.6 to $1.9.

News

Price Target

Analyst Ratings

EGHT

Morgan Stanley Maintains Underweight on 8x8, Lowers Price Target to $1.9

Mizuho analyst Siti Panigrahi maintains 8x8 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EGHT#NASDAQ">EGHT</a>) with a Underperform and lowers the price target from $2.5 to $2.

Mizuho Maintains Underperform on 8x8, Lowers Price Target to $2

Co says ‘The partnership enables improved patient engagement, streamlined healthcare workflows, and secure, compliant data management.'

Contracts

8x8 Highlights SpinSci Technology Partnership; Terms Not Disclosed

<h3>Gainers</h3>
<ul>
<li>SolarWinds (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SWI#NYSE">SWI</a>) stock moved upwards by 21.6% to $18.28 during Friday's pre-market session. The market value of their outstanding shares is at $3.1 billion. </li>
<li>Castellum (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/CTM#AMEX">CTM</a>) shares moved upwards by 14.22% to $1.14. The market value of their outstanding shares is at $88.1 million. </li>
<li>Cleanspark (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLSK#NASDAQ">CLSK</a>) stock rose 11.94% to $11.62. The market value of their outstanding shares is at $3.2 billion. As per the news, the Q1 earnings report came out yesterday. </li>
<li>Pagaya Techs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PGY#NASDAQ">PGY</a>) shares increased by 10.38% to $12.22. The market value of their outstanding shares is at $900.0 million. </li>
<li>TROOPS (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TROO#NASDAQ">TROO</a>) stock increased by 9.92% to $1.55. The company's market cap stands at $157.4 million. </li>
<li>Aurora Mobile (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JG#NASDAQ">JG</a>) shares increased by 8.99% to $10.3. The market value of their outstanding shares is at $61.6 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>BILL Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BILL#NYSE">BILL</a>) shares fell 32.5% to $65.0 during Friday's pre-market session. The market value of their outstanding shares is at $6.7 billion. As per the news, the Q2 earnings report came out yesterday. </li>
<li>Cyngn (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYN#NASDAQ">CYN</a>) stock fell 30.5% to $0.06. The market value of their outstanding shares is at $1.2 million. </li>
<li>Digital Ally (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DGLY#NASDAQ">DGLY</a>) stock decreased by 20.84% to $0.18. The market value of their outstanding shares is at $1.4 million. </li>
<li>NextTrip (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NTRP#NASDAQ">NTRP</a>) stock fell 16.11% to $5.26. The market value of their outstanding shares is at $8.3 million. </li>
<li>Lantronix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LTRX#NASDAQ">LTRX</a>) shares decreased by 15.01% to $3.57. The market value of their outstanding shares is at $137.3 million. The company's, Q2 earnings came out yesterday. </li>
<li>8x8 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EGHT#NASDAQ">EGHT</a>) shares decreased by 11.62% to $2.51. The company's market cap stands at $327.9 million. The company's, Q3 earnings came out 3 days ago. 
See Also: <a href="http://www.benzinga.com/money/tech-stocks/" title="www.benzinga.com/money/tech-stocks/">www.benzinga.com/money/tech-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Movers

BILL

CLSK

DGLY

LTRX

NTRP

TROO

12 Information Technology Stocks Moving In Friday's Pre-Market Session

8&#215;8, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EGHT#NASDAQ">EGHT</a>) reported mixed results for its third <a href="https://www.benzinga.com/quote/eght/earnings">quarter on Tuesday</a>.
The company posted quarterly earnings of 11 cents per share which beat the analyst consensus estimate of 9 cents per share. The company reported quarterly sales of $178.88 million which missed the analyst consensus estimate of $179.26 million.
&#8220;Our third quarter results highlight further progress and continued momentum in our transformation journey. We delivered solid financial performance, with record cash flow from operations and strong adoption of our AI-powered customer experience solutions, driving a 60% year-over-year increase in new products. As we move forward, our focus remains on enhancing customer value, accelerating growth, and driving long-term profitability. With a clear strategy and a strong team, I believe we are well-positioned to capitalize on the opportunities ahead,&#8221; said Samuel Wilson, Chief Executive Officer at 8&#215;8, Inc.
8&#215;8 lowered its FY2025 sales guidance from $714.00 million-727.00 million to $713.00 million-719.00 million.
8&#215;8 shares gained 4.4% to close at $2.84 on Tuesday.
These analysts made changes to their price targets on 8&#215;8 following earnings announcement.
<ul>
<li>Needham analyst Ryan Koontz maintained 8&#215;8 with a Buy and raised the price target from $3 to $3.5.</li>
<li>Barclays analyst Ryan Macwilliams maintained 8&#215;8 with an Equal-Weight and raised the price target from $2.5 to $3.</li>
</ul>
Considering buying EGHT stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="568" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/05073541/image-42-1024x568.png" alt="" class="wp-image-766985" style="width:704px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/05073541/image-42-1024x568.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/05073541/image-42-300x167.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/05073541/image-42-768x426.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/05073541/image-42.png 1126w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next:<a href="https://www.benzinga.com/trading-ideas/long-ideas/25/02/43460681/jim-cramer-says-no-to-bigbear-ai-recommends-buying-this-tech-stock"> </a>
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/25/02/43460681/jim-cramer-says-no-to-bigbear-ai-recommends-buying-this-tech-stock">Jim Cramer Says No To BigBear.ai, Recommends Buying This Tech Stock</a></li>
</ul>

Earnings

Markets

Trading Ideas

These Analysts Raise Their Forecasts On 8x8 Following Q3 Results

Barclays analyst Ryan Macwilliams maintains 8x8 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EGHT#NASDAQ">EGHT</a>) with a Equal-Weight and raises the price target from $2.5 to $3.

Barclays Maintains Equal-Weight on 8x8, Raises Price Target to $3

Needham analyst Ryan Koontz maintains 8x8 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EGHT#NASDAQ">EGHT</a>) with a Buy and raises the price target from $3 to $3.5.

Needham Maintains Buy on 8x8, Raises Price Target to $3.5

8x8 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EGHT#NASDAQ">EGHT</a>) released its Q3 earnings on Tuesday, February 4, 2025 at 04:05 PM.
Here's what's important from the earnings announcement.
<h3>Earnings</h3>
8x8 beat estimated earnings by 22.0%, reporting an EPS of $0.11 versus an estimate of $0.09.
Revenue was down $2.12 million from the same period last year.
<h3>Historical Earnings Summary</h3>
Last quarter the company beat on EPS by $0.01 which was followed by a 19.0% increase in the share price the next day.
Here's a look at 8x8's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q2 2025</th>
<th>Q1 2025</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.08</td>
<td>0.09</td>
<td>0.06</td>
<td>0.10</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.09</td>
<td>0.08</td>
<td>0.08</td>
<td>0.12</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>178.36M</td>
<td>178.72M</td>
<td>178.83M</td>
<td>183.49M</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>181.00M</td>
<td>178.15M</td>
<td>179.41M</td>
<td>181.01M</td>
</tr>
</tbody>
</table>

To track all earnings releases for 8x8 <a href="https://www.benzinga.com/quote/EGHT/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

8x8 Earnings Report: Q3 Overview

8x8 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EGHT#NASDAQ">EGHT</a>) reported quarterly earnings of $0.11 per share which beat the analyst consensus estimate of $0.09 by 22.22 percent. This is a 8.33 percent decrease over earnings of $0.12 per share from the same period last year. The company reported quarterly sales of $178.88 million which missed the analyst consensus estimate of $179.26 million by 0.21 percent. This is a 1.17 percent decrease over sales of $181.01 million the same period last year.

Earnings Beats

Earnings Misses

8x8 Q3 Adj $0.11 Beats $0.09 Estimate, Sales $178.88M Miss $179.26M Estimate

8x8 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EGHT#NASDAQ">EGHT</a>) lowers FY2025 sales outlook from $714.00 million-727.00 million to $713.00 million-719.00 million vs $720.22 million estimate.

Guidance

8x8 Lowers FY2025 Sales Guidance from $714.00M-727.00M to $713.00M-719.00M vs $720.22M Est

8x8 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EGHT#NASDAQ">EGHT</a>) sees Q4 sales of $175.000 million-181.000 million vs $181.93 million estimate.

8x8 Sees Q4 Sales $175.000M-181.000M vs $181.93M Est

ALGT

AMCR

AMGN

APAM

ARMK

ATEN

ATKR

AUDC

AVNW

AXTA

AZEK

AZPN

BALL

BERY

COLM

CRUS

CVRX

ENPH

ENVA

FICO

FLNG

FOXA

GBDC

GOOG

GOOGL

HLNE

HUBB

ICHR

IESC

INGR

INMD

INNV

INTA

JKHY

JNPR

KLIC

KTCC

LANC

LARK

LUMN

MDLZ

MLAB

MPLX

MRCY

MSGS

MTCH

MUFG

OCSL

OSCR

PINC

PYPL

RACE

Earnings Scheduled For February 4, 2025

Rosenblatt analyst Catharine Trebnick maintains 8x8 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EGHT#NASDAQ">EGHT</a>) with a Buy and lowers the price target from $3.5 to $3.3.

Rosenblatt Maintains Buy on 8x8, Lowers Price Target to $3.3

WIIM

APPS

AXTI

COHR

MSFT

MTSI

SHOP

SPCB

Shares of companies within the broader technology sector are trading higher amid overall market strength after CPI data was in line with estimates and core CPI rose by less than expected.

In the last three months, 7 analysts have published ratings on 8x8 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EGHT#NASDAQ">EGHT</a>), offering a diverse range of perspectives from bullish to bearish.
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">3</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Insights from analysts' 12-month price targets are revealed, presenting an average target of $2.84, a high estimate of $4.00, and a low estimate of $2.00. A 8.68% drop is evident in the current average compared to the previous average price target of $3.11. 
<img src="https://www.benzinga.com/files/images/story/2024/1734548409_0.png" alt="price target chart" />
<h2>Understanding Analyst Ratings: A Comprehensive Breakdown</h2>
The standing of 8x8 among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Meta Marshall</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Underweight</td>
<td>$2.60</td>
<td>$2.00</td>
</tr>
<tr>
<td>Siti Panigrahi</td>
<td>Mizuho</td>
<td>Lowers</td>
<td>Underperform</td>
<td>$2.50</td>
<td>$2.75</td>
</tr>
<tr>
<td>Michael Turrin</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Underweight</td>
<td>$2.00</td>
<td>$1.50</td>
</tr>
<tr>
<td>Siti Panigrahi</td>
<td>Mizuho</td>
<td>Raises</td>
<td>Neutral</td>
<td>$2.75</td>
<td>$2.50</td>
</tr>
<tr>
<td>Ryan Macwilliams</td>
<td>Barclays</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$2.50</td>
<td>$2.00</td>
</tr>
<tr>
<td>Catharine Trebnick</td>
<td>Rosenblatt</td>
<td>Lowers</td>
<td>Buy</td>
<td>$3.50</td>
<td>$4.00</td>
</tr>
<tr>
<td>Josh Nichols</td>
<td>B. Riley Securities</td>
<td>Lowers</td>
<td>Buy</td>
<td>$4.00</td>
<td>$7.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to 8x8. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of 8x8 compared to the broader market.</li>
<li>Price Targets: Gaining insights, analysts provide estimates for the future value of 8x8's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of 8x8's market position. Stay informed and make well-informed decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/EGHT/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on 8x8 analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap">you can start by tracking it here</a>.
<h2>All You Need to Know About 8x8</h2>
8x8 Inc provides contact-center-as-a-service and unified-communications-as-a-service software applications to approximately 2.5 million users. The company's unified platform enables omnichannel communication to assist employees in communicating across voice, video, text, chat, and contact centers. The Company also generates revenue from sales of hardware and professional services, which are complementary to the delivery of its integrated technology platform.. Geographically, it derives a majority of revenue from the United States.
<h3>Financial Insights: 8x8</h3>
Market Capitalization Analysis: Above industry benchmarks, the company's market capitalization emphasizes a noteworthy size, indicative of a strong market presence.
Negative Revenue Trend: Examining 8x8's financials over 3 months reveals challenges. As of 30 September, 2024, the company experienced a decline of approximately -2.16% in revenue growth, reflecting a decrease in top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Information Technology sector.
Net Margin: 8x8's net margin is below industry averages, indicating potential challenges in maintaining strong profitability. With a net margin of -8.03%, the company may face hurdles in effective cost management.
Return on Equity (ROE): The company's ROE is below industry benchmarks, signaling potential difficulties in efficiently using equity capital. With an ROE of -13.57%, the company may need to address challenges in generating satisfactory returns for shareholders.
Return on Assets (ROA): 8x8's ROA is below industry averages, indicating potential challenges in efficiently utilizing assets. With an ROA of -1.94%, the company may face hurdles in achieving optimal financial returns.
Debt Management: With a high debt-to-equity ratio of 4.2, 8x8 faces challenges in effectively managing its debt levels, indicating potential financial strain.
<h2>The Core of Analyst Ratings: What Every Investor Should Know</h2>
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

A Glimpse Into The Expert Outlook On 8x8 Through 7 Analysts

8x8 shares are trading higher after Morgan Stanley raised its price target on the stock from $2 to $2.6.

Morgan Stanley analyst Meta Marshall maintains 8x8 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EGHT#NASDAQ">EGHT</a>) with a Underweight and raises the price target from $2 to $2.6.

Morgan Stanley Maintains Underweight on 8x8, Raises Price Target to $2.6

8x8 shares are trading lower after Mizuho downgraded the stock from Neutral to Underperform and cut its price target from $2.75 to $2.5.

U.S. stock futures were higher this morning, with the Nasdaq futures gaining around 150 points on Friday.
Shares of Candel Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CADL#NASDAQ">CADL</a>) fell sharply in today's pre-market trading after the company announced the <a href="https://www.benzinga.com/quote/CADL/news">pricing of public offering</a>.
Candel Therapeutics shares dipped 30.9% to $6.77 in the pre-market trading session.
Here are some other stocks moving lower in pre-market trading.
<ul>
<li>Alumis Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALMS#NASDAQ">ALMS</a>) shares declined 6.1% to $8.20 in pre-market trading.</li>
<li>Savers Value Village, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SVV#NYSE">SVV</a>) fell 6.1% to $9.01 in pre-market trading.</li>
<li>8&#215;8, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EGHT#NASDAQ">EGHT</a>) fell 4.5% to $2.98 in pre-market trading. Mizuho analyst Siti Panigrahi downgraded 8&#215;8 from Neutral to Underperform and lowered the price target from $2.75 to $2.5.</li>
<li>Bicycle Therapeutics plc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BCYC#NASDAQ">BCYC</a>) shares declined 4.1% to $19.30 in pre-market trading. On Thursday, Bicycle Therapeutics announced that it presented data showing the enhanced anti-tumor activity of zelenectide pevedotin monotherapy in breast cancer patients with NECTIN4 gene amplification at the 2024 San Antonio Breast Conference Symposium.</li>
<li>CECO Environmental Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CECO#NASDAQ">CECO</a>) fell 3.1% to $31.71 in pre-market trading.</li>
<li>Montrose Environmental Group, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MEG#NYSE">MEG</a>) fell 2.3% to $15.77 in pre-market trading.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/12/42460676/jim-cramer-amd-ceo-lisa-su-built-an-amazing-company">Jim Cramer Says This CEO &#8216;Built An Amazing Company,&#8217; Recommends Buying Netflix</a></li>
</ul>

Pre-Market Outlook

ALMS

BCYC

CADL

CECO

Candel Therapeutics, 8x8 And Other Big Stocks Moving Lower In Friday's Pre-Market Session

Mizuho analyst Siti Panigrahi downgrades 8x8 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EGHT#NASDAQ">EGHT</a>) from Neutral to Underperform and lowers the price target from $2.75 to $2.5.

Downgrades

Mizuho Downgrades 8x8 to Underperform, Lowers Price Target to $2.5

Press Releases

8x8, Inc. Strengthens Leadership Team to Accelerate CX Transformation

CallCabinet Partners with 8x8 to Deliver Integrated Compliance Recording Across the Entire 8x8 Platform for CX

8x8 Transforms Patient Engagement with EHR-Compliant Solutions Through SpinSci Technology Partnership

8x8, Inc. Announces Participation in Upcoming Investor Events

Increasing Customer Adoption of AI-powered Self-Service Drives Momentum in 8x8 CPaaS APIs

8x8 Earns 5-Star Rating in the 2025 CRN® Partner Program Guide

New 8x8® AI Orchestrator Creates Seamless Decision Flows Between AI Bots to Deliver Frictionless Customer Experiences

8x8® Contact Center Adds RCS Business Messaging Support to Transform Customer Engagement Through Interactive, Hyper-Personalized Two-Way Communication

8x8 Engage™ Enables All Customer-facing Teams to Deliver Superior CX on Digital Channels

8x8® Announces JourneyIQ to Deliver Integrated AI-powered Customer Journey Intelligence Across the Organization

AudioEye

Agora

Digital Turbine

Arqit Quantum

Bit Digital

CoreCard

Cheetah Mobile Inc. American Depositary Shares, each representing fifty (50) Class A Ordinary Shares

Cheetah Mobile

Cerence

Digimarc

Domo

Viant Technology

eGain

Expensify

Helport AI

Kaltura

CS Disco

Materialise NV - American Depositary Shares

Materialise

OneConnect Financial Technology Co., Ltd. American Depositary Shares, each representing thirty ordinary shares

Comments

8x8

8x8 (EGHT) Opzioni

8x8 (NASDAQ:EGHT) Azioni, Catena delle Opzioni

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO